###begin article-title 0
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports
###end article-title 0
###begin title 1
Background:
###end title 1
###begin p 2
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Birt-Hogg-Dube syndrome (BHDS) (MIM 135150) is an autosomal dominant predisposition to the development of follicular hamartomas (fibrofolliculomas), lung cysts, spontaneous pneumothorax, and kidney neoplasms. Germline mutations in BHD are associated with the susceptibility for BHDS. We previously described 51 BHDS families with BHD germline mutations.
###end p 2
###begin title 3
Objective:
###end title 3
###begin p 4
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
To characterise the BHD mutation spectrum, novel mutations and new clinical features of one previously reported and 50 new families with BHDS.
###end p 4
###begin title 5
Methods:
###end title 5
###begin p 6
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 218 223 <span type="species:ncbi:9606">human</span>
Direct bidirectional DNA sequencing was used to screen for mutations in the BHD gene, and insertion and deletion mutations were confirmed by subcloning. We analysed evolutionary conservation of folliculin by comparing human against the orthologous sequences.
###end p 6
###begin title 7
Results:
###end title 7
###begin p 8
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 893 896 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1190 1193 1190 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 322 329 <span type="species:ncbi:9606">patient</span>
###xml 639 647 <span type="species:ncbi:9606">Patients</span>
###xml 809 817 <span type="species:ncbi:9606">patients</span>
###xml 877 885 <span type="species:ncbi:9606">patients</span>
###xml 1057 1065 <span type="species:ncbi:9606">patients</span>
The BHD mutation detection rate was 88% (51/58). Of the 23 different germline mutations identified, 13 were novel consisting of: four splice site, three deletions, two insertions, two nonsense, one deletion/insertion, and one missense mutation. We report the first germline missense mutation in BHD c.1978A>G (K508R) in a patient who presented with bilateral multifocal renal oncocytomas. This mutation occurs in a highly conserved amino acid in folliculin. 10% (5/51) of the families had individuals without histologically confirmed fibrofolliculomas. Of 44 families ascertained on the basis of skin lesions, 18 (41%) had kidney tumours. Patients with a germline BHD mutation and family history of kidney cancer had a statistically significantly increased probability of developing renal tumours compared to patients without a positive family history (p = 0.0032). Similarly, patients with a BHD germline mutation and family history of spontaneous pneumothorax had a significantly increased greater probability of having spontaneous pneumothorax than BHDS patients without a family history of spontaneous pneumothorax (p = 0.011). A comprehensive review of published reports of cases with BHD germline mutation is discussed.
###end p 8
###begin title 9
Conclusion:
###end title 9
###begin p 10
BHDS is characterised by a spectrum of mutations, and clinical heterogeneity both among and within families.
###end p 10
###begin p 11
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 469 472 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 639 640 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 750 753 750 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 850 853 850 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 969 970 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 970 971 970 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
Birt-Hogg-Dube syndrome (BHDS) (MIM 135150) is an autosomal dominantly inherited genodermatosis that predisposes to the development of cutaneous hamartomas (fibrofolliculomas), kidney neoplasms, lung cysts and spontaneous pneumothorax.12 We mapped the BHD locus to the short arm of chromosome 17(17p11.2).3 Subsequently, we found that germline mutations in BHD (GenBank accession number AF517523) (also known as FLCN), were associated with the susceptibility for BHDS.4BHD is composed of 14 exons. We previously reported 51 BHDS families with germline mutations in BHD, and to date more than 40 unique mutations in BHD have been reported.4-16 Germline insertion or deletion of a cytosine in the hypermutable polycytosine (C8) tract in exon 11 of the BHD gene has been detected in 53% of BHDS families and is suggested as a mutation "hot spot".6 Most BHD germline mutations are frameshift or nonsense mutations that are predicted to truncate the BHD protein, folliculin.4-16
###end p 11
###begin p 12
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bhd</italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 449 450 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bhd</italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bhd</italic>
###xml 639 642 639 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 226 229 <span type="species:ncbi:10116">rat</span>
###xml 464 467 <span type="species:ncbi:10116">rat</span>
###xml 618 622 <span type="species:ncbi:10116">rats</span>
Two naturally occurring renal cancer syndromes in animals have been described: hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in German shepherd dogs1718 and hereditary renal carcinoma in the Nihon rat.1920 Germline mutations in the BHD ortholog genes have been identified in affected animals with these renal cancer syndromes: a missense mutation in exon 7 in the canine bhd gene,21 and an insertion of a cytosine in a C5 tract in the rat bhd gene.22 Furthermore, a high frequency of loss of heterozygosity (LOH) of the wild type bhd allele has been demonstrated in renal tumours in Nihon rats suggesting that BHD functions as a tumour suppressor gene.1920
###end p 12
###begin p 13
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 305 308 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 421 424 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
BHD is predicted to encode a 579 amino acid protein, folliculin, which is highly conserved among species. BHD mRNA is expressed in a variety of tissues including stromal cells, the distal nephron of the kidney, type I pneumocytes of the lung, and skin and its appendages.23 However, reduced expression of BHD was seen in renal tumours from patients with BHDS,23 consistent with the reported inactivation of the wild-type BHD allele by somatic mutation or LOH in BHD associated renal tumours.24
###end p 13
###begin p 14
###xml 121 131 121 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 121 131 <span type="species:ncbi:7227">Drosophila</span>
Until recently the function of folliculin was unknown. Taking a genetic approach, Singh and colleagues demonstrated that Drosophila DBHD is required for male germline stem cell maintenance in the fly testis and functions downstream of the JAK/STAT and decapentaplegic signal transduction pathways.25 Recently, Baba and colleagues identified a novel folliculin-interacting protein, FNIP1, by co-immunoprecipitation studies in mammalian cells. They found that FNIP1 binds to 5'-AMP activated protein kinase, a negative regulator of mTOR suggesting that folliculin and its interacting partner may be involved in the AMPK and mTOR signalling pathways.26
###end p 14
###begin p 15
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 238 241 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Understanding the mutation spectrum as well as defining the clinical features of BHDS is important for diagnosis and BHD mutation screening, as well as for surveillance and treatment. In this study, we investigated new clinical features, BHD germline mutations, and potential genotype-phenotype associations in 51 families with BHDS.
###end p 15
###begin title 16
PATIENTS AND METHODS
###end title 16
###begin title 17
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient recruitment and evaluation
###end title 17
###begin p 18
###xml 1171 1172 1171 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 1327 1330 1327 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 872 879 <span type="species:ncbi:9606">patient</span>
All patients were evaluated at the National Institutes of Health (NIH) Clinical Center in consecutive order in a protocol approved by the Institutional Review Board of the National Cancer Institute (NCI). All members of families screened for BHDS who participated in this study gave written informed consent. We recruited BHDS families through referrals from the 11 000 members of the American Academy of Dermatology and were also referred families for treatment of familial kidney cancer. Forty-four families were ascertained because of cutaneous signs of BHDS and seven families were referred to the Urologic Oncology Branch for evaluation and treatment of familial kidney cancer. Medical histories were obtained (fibrofolliculomas, spontaneous pneumothorax and renal tumours) and physical examinations were performed. History of other neoplasms and pneumothorax in the patient or family were also recorded. Each individual had a detailed dermatologic examination and skin biopsies were obtained of selected lesions. Computed tomography (CT) scans of the chest and abdomen were used to screen for pulmonary and renal abnormalities respectively, as previously described.6 Outside medical records and pathology reports were reviewed, and tissue specimen blocks and slides were reviewed by NIH pathologists. Blood was drawn for BHD mutation analysis.
###end p 18
###begin title 19
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
BHD mutation analysis
###end title 19
###begin p 20
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
DNA was extracted from peripheral blood leucocytes according to standard procedures. Methods for identification of exon/intron boundaries and high throughput DNA sequencing were as previously described.4 At least 160 unrelated control individuals were examined for each disease associated sequence variant. Insertion and deletion mutations were confirmed by subcloning using Topo Cloning Kit (Invitrogen) and sequencing.
###end p 20
###begin title 21
Statistical analysis
###end title 21
###begin p 22
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Data collected from BHDS patients included: presence of fibrofolliculomas, presence of renal tumours, gender, history and number of pneumothoraces, and presence of lung cysts. Analyses with respect to dichotomous parameters and their relationship to presence or absence of a pneumothorax, renal tumour or fibrofolliculomas were done using a Fisher's exact test. Mehta's modification to Fisher's exact test was used to compare unordered categorical data to a dichotomous parameter.27 An exact Cochran-Armitage test for trend was used to determine the association between the number of pneumothoraces considered in ordered categories, and the presence or absence of a family history of pneumothoraces.28 All p values are two-sided and were not adjusted for multiple comparisons. However, in view of the exploratory nature of the study and the large number of comparisons performed, only p values <0.01 should be considered as being associated with statistically significant tests, while those between 0.01 and 0.05 would be considered trends.
###end p 22
###begin title 23
Multiple sequence alignment of the folliculin protein
###end title 23
###begin p 24
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 116 126 <span type="species:ncbi:9598">chimpanzee</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 143 146 <span type="species:ncbi:10116">rat</span>
###xml 148 151 <span type="species:ncbi:9615">dog</span>
###xml 153 158 <span type="species:ncbi:9796">horse</span>
###xml 160 163 <span type="species:ncbi:9913">cow</span>
###xml 165 172 <span type="species:ncbi:9031">chicken</span>
###xml 180 189 <span type="species:ncbi:7955">zebrafish</span>
We analysed evolutionary conservation by comparing human folliculin against the orthologous folliculin sequences of chimpanzee, monkey, mouse, rat, dog, horse, cow, chicken, frog, zebrafish and sea urchin from the National Center for Biotechnology information (NCBI) protein database.29 The ClustalW Multiple Sequence Alignments algorithm (European Bioinformatics Institute) was used to evaluate sequence conservation.30
###end p 24
###begin title 25
Literature review
###end title 25
###begin p 26
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 539 542 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
We performed an electronic search from 2001 to 2007 designed to capture all reported cases of BHDS with BHD (also known as FLCN) germline mutations. Cases were excluded if mutations were somatic (not shown in a second tissue like normal kidney or peripheral blood). However, cases were still included in the review even if the method of mutation detection was not included. In total, 11 articles were ultimately included.5-15 Cases were cross-referenced in order to avoid duplication of cases. Only one case was reported twice.78 Germline BHD mutation, presence of fibrofolliculomas, renal tumours, lung cysts, and history of pneumothorax, regardless of radiological methods, were recorded.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
BHD mutation analysis
###end title 28
###begin p 29
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 482 489 482 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 858 865 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 867 872 867 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0321-f01">fig 1</xref>
###xml 1234 1235 1234 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
Ninety-eight individuals from 58 families were screened for BHD mutations. Using direct sequencing analysis we identified BHD germline mutations in 89 individuals from 51 families with BHDS (88% (51/58) BHD mutation detection rate). Direct sequence analysis of the 14 coding exons and splice site junctions of BHD revealed 23 unique germline mutations including: one missense, eight deletions, four insertions, one insertion/deletion, three nonsense, and six splice site mutations (table 1). Of these 23 germline mutations, 13 were novel and consisted of: three deletions (c.602delA, c.1707delC, c.1983-5delGAG), two insertions (c.802insA, c.1741insA), an insertion/deletion (c.774-5delGTinsCAC), four splice site mutations (IVS4-2 A>G, IVS7+1 G>T, c.1755 G>A, IVS12+1 G>A), one missense (c.1978A>G [K508R]) and two nonsense (c.1065-6delGCinsTA, c.1670C>G) (table 1, fig 1). Splice site and missense mutations were not detected in more than 160 normal individuals. All insertions and deletions were confirmed by subcloning. The c.1755 G>C and c.1755 G>A affect the last coding nucleotide of exon 11 resulting in aberrant mRNA splicing. Splicing alteration of exon 11 as a consequence of this mutation has been previously demonstrated.7
###end p 29
###begin title 30
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
BHD mutations newly characterised in families with Birt-Hogg-Dube syndrome (BHDS). Sequencing chromatograms of genomic DNA from control subjects and patients are shown on the left. The arrows indicate the position of the identified nucleotide changes. The corresponding pedigrees are shown on the right. FF, fibrofolliculoma; MT, mutant; WT, wildtype.
###end title 30
###begin title 31
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Spectrum of germline BHD mutations and phenotypic features of 51 National Cancer Institute families with Birt-Hogg-Dube syndrome
###end title 31
###begin p 32
AF, angiofibroma; BCC, basal cell carcinoma; CTN, connective tissue nevus; DFSP, dermatofibrosarcoma protuberans; FF, fibrofolliculoma; L, lipoma; LM, cutaneous leiomyoma; MM, malignant melanoma; PFF, perifollicular fibroma; LS, cutaneous leiomyosarcoma; SCC, squamous cell carcinoma; SH, sebaceous hyperplasia; TD, trichodiscoma.
###end p 32
###begin p 33
FF diagnosis is based on histological diagnosis only.
###end p 33
###begin p 34
*Families ascertained on the basis of kidney tumours. daggerIn these cases of deletions in a mononuclear tract, the last nucleotide is given. The c.514delT mutation was formerly reported as c.513delT and the c.1039delG was formerly reported as c. 1036delG.
###end p 34
###begin p 35
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 89 96 89 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1053 1060 1053 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
BHD mutations were identified affecting only translated exons 4, 5, 6, 9, 11, 12 and 13 (table 1). Exon 11 was the most frequent site of mutation representing 47% (24/51) of the BHDS families. A total of 19 families had a germline BHD mutation in the mononucleotide tract of eight cytosines (c.1733-1740), the mutation "hotspot" in exon 11. Seventy-four per cent (14/19) had a cytosine insertion (c.1733insC) and 26% (5/19) had a cytosine deletion (c.1733delC). Three of the four families with mutations in exon 12 shared a common mutation (c.1844C>G). Four families had a BHD mutation in exon 5. Exons 9 and 6 were each the site of mutations in three families. All three families with mutations in exon 9 had the 28-bp duplication (c.1378-1405dup). Two families had unique mutations in exon 4 and two families had a unique mutation in exon 13. Nine families had intronic mutations that were predicted to cause exon skipping: three in intron 7 (IVS7+1G>T), four in intron 4 (IVS4-2 A>G), one in intron 9 (IVS9+2 T>G) and one in intron 12 (IVS12+1 G>A) (table 1). The most 5' mutation (c.514delT) occurred in exon 4 (20 aa from the initiation codon) and is predicted to truncate the protein 34 amino acids downstream. The most 3' mutation (c.1983-5delGAG) occurred in exon 13 and it is predicted to produce a deletion of a single amino acid at position 510.
###end p 35
###begin p 36
###xml 244 249 244 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0321-f02">fig 2</xref>
###xml 439 444 439 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0321-f02">fig 2</xref>
###xml 363 373 <span type="species:ncbi:9598">chimpanzee</span>
###xml 375 380 <span type="species:ncbi:9796">horse</span>
###xml 382 387 <span type="species:ncbi:10090">mouse</span>
###xml 389 392 <span type="species:ncbi:10116">rat</span>
###xml 394 397 <span type="species:ncbi:9615">dog</span>
###xml 399 402 <span type="species:ncbi:9913">cow</span>
###xml 404 411 <span type="species:ncbi:9031">chicken</span>
###xml 413 422 <span type="species:ncbi:7955">zebrafish</span>
The novel missense mutation (K508R) was also confirmed by a CLIA approved laboratory and it was not present in DNA from 160 unrelated control individuals. The K508R mutation leads to a change from lysine to arginine at amino acid position 508 (fig 2). ClustalW multiple protein sequence alignments showed that amino acid K508 of folliculin is highly conserved in chimpanzee, horse, mouse, rat, dog, cow, chicken, zebrafish and sea urchin (fig 2). In addition, a block of continuous high conservation was shown between amino acids L507 to V515. The conservation across species suggests an important biological role for K508 amino acid in folliculin.
###end p 36
###begin title 37
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 99 106 <span type="species:ncbi:9606">patient</span>
Novel BHD missense mutation (K508R). (A) Genomic sequence of control. (B) Genomic sequence of BHDS patient with the c.1978A>G (K508R) mutation. (C) Multiple sequence alignment. The amino acid residues are coloured according to their chemical properties. (D) Degree of conservation. The numerical index reflects the degree of conservation of the physical-chemical properties in the alignment. Star (*) indicates amino acids 100% identical in the alignment (highest score). The next most conserved group is composed of substitutions in amino acids with the same physical chemical class.
###end title 37
###begin title 38
Clinical features
###end title 38
###begin p 39
###xml 49 56 49 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 155 158 <span type="species:ncbi:9606">men</span>
###xml 166 171 <span type="species:ncbi:9606">women</span>
Patients' clinical characteristics are listed in table 1. Our cohort included a total of 89 individuals from 51 families with BHD mutations. There were 37 men and 52 women with a median age of 54 years. The number of affected individuals in a family ranged from 1 to 10. Thirty-three families had only one member affected with BHDS who participated in the study.
###end p 39
###begin title 40
Cutaneous findings
###end title 40
###begin p 41
###xml 974 977 974 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Ninety per cent (46/51) of families with BHDS had individuals with multiple 1-5 mm white or skin coloured papules distributed over the face, neck and/or upper trunk and a histologically confirmed fibrofolliculoma (FF). Fifty-seven per cent (26/46) of BHDS families with a histologically confirmed FF also had individuals with a second histologically confirmed cutaneous lesion associated with BHDS including: angiofibroma (AF) or trichodiscoma (TD) (12 families), perifollicular fibroma (PFF) (11 families), and both TD and PFF (three families). In 10% (5/51) of BHDS families the clinical diagnosis of FF was not confirmed histologically. However, four of these families had at least one individual with a histologically proven TD or AF (one individual in each of two families), or PFF (one individual in one family), or both an AF and a PFF (one individual in one family). One family had no individuals with FF, PFF, TD or AF. All of these individuals also had a germline BHD mutation. In addition, three of these families had individuals with a history of spontaneous pneumothorax and/or lung cysts supporting the clinical diagnosis of BHDS.
###end p 41
###begin p 42
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 308 315 308 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
Other dermatologic conditions histologically confirmed in individuals with a germline BHD mutation included: basal cell carcinoma (four families), connective tissue nevus (two families), sebaceous hyperplasia (two families), squamous cell carcinoma (SCC) (one family), and malignant melanoma (two families) (table 1). Two families had cutaneous soft tissue tumours: family 258 had one individual with a cutaneous leiomyoma (LM) and family 262 had one individual with a dermatofibrosarcoma protuberans (DFSP) and another with a cutaneous leiomyosarcoma (LS).
###end p 42
###begin title 43
Kidney tumour findings
###end title 43
###begin p 44
###xml 93 100 93 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 103 106 <span type="species:ncbi:9606">Men</span>
###xml 160 165 <span type="species:ncbi:9606">women</span>
###xml 178 186 <span type="species:ncbi:9606">Patients</span>
Overall 34% (30/89) of individuals and 49% (25/51) of families with BHDS had kidney tumours (table 1). Men (13 cases) developed renal tumours about as often as women (17 cases). Patients had either bilateral, multifocal or unilateral renal tumours (>0.5 cm lesion).
###end p 44
###begin p 45
###xml 453 456 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 779 782 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Among 25 families with kidney tumours, 18 (72%) were recruited based on cutaneous manifestations suggestive of BHDS and/or the histologic diagnosis of fibrofolliculoma and seven (28%) were recruited based on kidney tumours. Approximately 41% (18/44) of families presenting with cutaneous manifestations had kidney tumours. We observed that 88% of BHDS families with renal tumours had only one individual with renal tumours even after screening multiple BHD gene mutation carriers for renal tumours with abdominal CT or magnetic resonance imaging (MRI) of the kidneys. Only three families had multiple living individuals affected with kidney tumours. Family 279 and family 288 each had two living cases and family 262 had four cases. An individual from family 297 with a germline BHD mutation presented with bilateral multifocal renal oncocytomas as the only sign of BHDS. He had no skin papules, history of pneumothorax or lung cysts on CT imaging.
###end p 45
###begin title 46
Pulmonary findings
###end title 46
###begin p 47
###xml 114 121 114 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 570 577 570 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
###xml 463 471 <span type="species:ncbi:9606">patients</span>
Eighty-eight per cent (45/51) of the BHDS families and 84% (75/89) of BHDS patients had lung cysts on CT imaging (table 1). Fifty-three per cent (27/51) of BHDS families and 38% (34/89) of individuals with BHDS had a history of spontaneous pneumothorax. Most patients with a history of pneumothorax had lung cysts by chest CT imaging (table 1). Thirty-four individuals had a total of 92 spontaneous pneumothoraces. Nineteen patients had two pneumothoraces, three patients had four pneumothoraces, three had five pneumothoraces, and one experienced seven pneumothoraces (table 1).
###end p 47
###begin title 48
Family history
###end title 48
###begin p 49
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
###xml 396 404 <span type="species:ncbi:9606">patients</span>
###xml 611 619 <span type="species:ncbi:9606">patients</span>
We found that 18 of 31 patients (58%) with a family history of pneumothorax developed pneumothoraces compared to 16 of 57 patients (28%) without this family history (p = 0.011). Among patients with BHDS, there was a statistically significant trend toward having a greater number of pneumothoraces if the patients had a family history of pneumothoraces compared to the number of pneumothoraces in patients who did not have this family history (p = 0.0022, by an exact Cochran-Armitage trend test). However, family history of pneumothorax was not associated with an increased risk of kidney tumours. Twelve of 34 patients with a family history of pneumothoraces had kidney tumours compared to 18 of 55 without this family history (p = 0.82).
###end p 49
###begin p 50
###xml 5 13 <span type="species:ncbi:9606">patients</span>
BHDS patients with a family history of kidney tumours had a statistically significantly increased probability of having renal tumours, with 16 of 28 (57%) individuals having these tumours among those with a family history for this condition as compared to 14 of 61 (23%) without a family history of kidney tumours (p = 0.0032). However, we observed that a family history of renal tumours was not associated with an increased risk of lung cyst (p = 0.32) or pneumothrorax (p = 0.16).
###end p 50
###begin title 51
Variable expression of phenotypic manifestations
###end title 51
###begin p 52
###xml 99 106 99 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 678 685 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
Variable phenotypic expression may be observed among families and within members of BHDS families (table 1). Among the 51 families with BHDS: 25% (13/51) had FFs, a history of spontaneous pneumothorax and renal tumours; 24% (12/51) had both FFs and a history of spontaneous pneumothorax but no renal tumours; 18% (9/51) had both FFs and kidney tumours but no individuals with a history of pneumothorax; 24% (12/51) had FFs but no renal tumour or history of pneumothorax; 4% (2/51) had no FFs, renal tumour or a history of pneumothorax; 2% (1/51) had renal tumour but no FFs or a history of pneumothorax; and 4% (2/51) had renal tumours and a history of pneumothorax but no FFs (table 1).
###end p 52
###begin title 53
Other clinical findings
###end title 53
###begin p 54
###xml 454 461 454 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 162 170 <span type="species:ncbi:9606">patients</span>
Among the BHDS patients in the present study, two had parotid gland oncocytomas diagnosed at ages 20 and 39 years. Non-renal cancers that occurred among the BHDS patients included two cases of colon cancer and thyroid cancer, respectively; and single cases of squamous cell carcinoma (SCC) of the head and neck, Hodgkin's disease, uterine cancer, prostate cancer, breast cancer, and SCC of the cervix. Other tumours were rhabdomyoma and an adrenal mass (table 1).
###end p 54
###begin title 55
Genotype-phenotype correlations
###end title 55
###begin title 56
BHD mutation hotspot: c.1733insC and c.1733delC
###end title 56
###begin p 57
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 394 397 394 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 906 909 906 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1051 1054 1051 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1113 1114 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
There was no association between BHD mutation hot spot versus all other BHD mutations, and presence of FFs (p = 0.78), presence of lung cysts (p = 0.76) or presence of pneumothoraces (p = 1.0). We also investigated for genotype-phenotype correlation among c.1733insC and c.1733delC BHD mutation carriers. The frequency of individuals with histologically proven FFs was similar among c.1733insC BHD mutation carriers (88% (22/25)) and c.1733delC BHD mutation carriers (78% (7/9)) (p = 0.59). Lung cysts were detected similarly among c.1733insC (84% (21/25)) and c.1733delC BHD mutation carriers (100% (9/9)) (p = 0.55). History of spontaneous pneumothorax was somewhat more common among c.1733delC (56% (5/9)) mutation carriers than among c.1733insC carriers (32% (8/25)) but not statistically significant (p = 0.25). Renal tumours were more common among c.1733delC (56% (5/9)) than c.1733insC (24% (6/25)) BHD mutation carriers but not statistically significant (p = 0.11). To explore further potential genotype-phenotype correlations we combined the BHD mutation hotspot data from our present and previous study.6 Our analyses showed that c.1733insC mutation carriers and c.1733delC mutation carriers had similar frequencies of FFs (85% (66/78) vs 84% (27/32) p = 1.00), lung cysts detected on thoracic CT scans (86% (56/65) vs 84% (22/26) p = 1.00), spontaneous pneumothorax (36% (31/87) vs 40% (14/35) p = 0.68) and renal tumours (29% (19/65) vs 24% (6/25) p = 0.79). Therefore, in general there were no statistically significant phenotypic differences among c.1733insC and c.1733delC carriers in BHDS families seen at NCI.
###end p 57
###begin title 58
Other types of mutations
###end title 58
###begin p 59
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 617 625 <span type="species:ncbi:9606">patients</span>
There was no association between BHD mutation status (no mutation vs mutation), mutation types ((insertion, deletion, nonsense, missense and splice site) (insertion vs other types of mutation), (deletion vs other types of mutation), (nonsense vs other types of mutation), (splice site vs other types of mutation), (missense vs other types of mutation), (frameshift vs other types of mutation), (intron vs exon mutations)), and cutaneous affected ((FF vs no FF) or (FF vs TD and/or PFF)), lung cyst (lung cyst vs no lung cysts ) or pneumothorax (history of pneumothorax vs no history of pneumothorax) in our cohort of patients.
###end p 59
###begin title 60
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Review of published reports of BHD germline mutations
###end title 60
###begin p 61
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 455 456 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t02">table 2</xref>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 159 162 <span type="species:ncbi:9606">men</span>
###xml 170 175 <span type="species:ncbi:9606">women</span>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 352 357 <span type="species:ncbi:9606">women</span>
###xml 362 365 <span type="species:ncbi:9606">men</span>
We reviewed cases with published BHD germline mutations and general clinical characteristics associated with BHDS.5-15 We previously reported 177 patients (88 men and 89 women) with BHD mutations from 51 BHDS families.6 Excluding the BHDS patients reported by NCI,6 a total of 85 individuals with BHD germline mutations have been reported including 35 women, 41 men and nine individuals in whom the gender was unspecified ranging from 12-77 years of age57-15 (table 2). The number of affected individuals in a family ranged from 1-12.
###end p 61
###begin title 62
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Summary of reviewed reports with BHD germline mutations and general clinical characteristics, excluding National Cancer Institute reports
###end title 62
###begin p 63
Bx, biopsy; CT, computed tomography; FF, fibrofolliculoma; HRCT, high resolution computed tomography; Hx, medical history; MRI, magnetic resonance imaging; Neg, negative; Pos, positive; Ukn, unknown.
###end p 63
###begin p 64
###xml 29 30 29 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 30 31 30 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
*One case was reported twice.78
###end p 64
###begin title 65
BHD germline mutations
###end title 65
###begin p 66
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 230 237 230 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t02">table 2</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 241 242 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 448 449 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 534 537 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 640 641 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 785 786 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 786 787 786 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 790 791 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 863 866 863 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 946 947 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 947 948 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 950 951 950 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 1187 1188 1187 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 1188 1189 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1189 1190 1189 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1192 1193 1192 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
Excluding our previously reported 22 BHD germline mutations,46 18 unique BHD germline mutations have been reported by other investigators including: seven deletion, three insertion, three nonsense, and five splice-site mutations (table 2).57-15 Of a total of 40 BHD germline mutations reported to date, only four mutations (c.1065-6delGCinsTA, c. 1733insC, c. 1733delC and 1884C>T) were reported by both the NCI BHDS group and other investigators.4-912-14 A family with the c.875delC mutation was described in two different studies.78BHD mutations have been reported affecting all translated exons,4-14 with the exception of exons 8 and 10.4-15 Exon 11 was the most frequent site of mutations (c.1733insC/1733delC, c.1755G>C) present in 125 individuals from 40 unrelated BHDS families.4-912-14 The hot spot mutation (c.1733insC or c.1733delC) was the most common BHD mutation reported to date in a total of 124 individuals from 39 BHDS families.4-912-14 Seventy-nine individuals from 28 families (18 NCI and 10 other groups) were reported to have the c.1733insC mutation and 45 individuals from 11 families (nine NCI and two other groups) were reported as having the c.1733delC mutation.4-912-14
###end p 66
###begin p 67
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 513 514 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
The most 5' BHD mutation reported occurred at nucleotide 454 (c. 458delG) in exon 4 affecting the initiator codon of BHD.14 Other BHD germline mutations have been previously reported in exon 4: c.690delTCGG predicted to result in a termination codon 50 amino acids downstream11 and c.514delT predicted to result in a premature termination codon at codon 34.6 The most 3' mutation reported occurred at nucleotide 2034 (c.2034 C>T) in exon 14 and was predicted to produce a premature termination codon at codon 527.6 No additional BHD mutations have been reported in exon 14.
###end p 67
###begin title 68
Clinical features
###end title 68
###begin p 69
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t02">table 2</xref>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 364 365 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
In the previously reported NCI BHDS cohort, 143 patients with BHD mutations had their skin papules biopsied and evaluated histologically. Of these 143 cases, 122 (85%) were diagnosed with a histologically proven FF.6 Excluding the NCI BHDS patients reported,6 73% (43/59) of individuals with germline mutations in BHD had a histologically confirmed FF (table 2).57-15 In five individuals with germline BHD mutations, FF was not confirmed histologically but they had a histologically proven trichodiscoma.8
###end p 69
###begin p 70
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
###xml 406 413 <span type="species:ncbi:9606">patient</span>
###xml 664 671 <span type="species:ncbi:9606">patient</span>
###xml 813 820 <span type="species:ncbi:9606">patient</span>
###xml 959 966 <span type="species:ncbi:9606">patient</span>
We previously reported 35 patients with BHD germline mutations who developed renal tumours.6 The frequency of renal tumour among patients with BHD germline mutations seen at the NIH clinical centre or in field trips was 22% (35/162) or 20% (35/177) of all patients of whom blood was collected and screened for mutations.6 Two BHDS patients died of metastatic kidney cancer after radical nephrectomy.31 One patient underwent bilateral nephrectomies for multiple tumours and received a kidney transplant. Pathological examination revealed that his largest tumour was an 8 cm clear cell renal cell carcinoma (RCC) and the other tumours had multiple histologies. This patient had biopsy proven paraspinal metastasis (clear cell histology) 56 months after his initial surgery and he died shortly thereafter. The other patient had an 8 cm predominantly clear cell RCC with areas of tubular papillary and chromophobe histology that invaded the perinephric fat. This patient had retroperitoneal recurrence 5 months after surgery, eventually developed osseous metastases and died 20 months postoperatively.31
###end p 70
###begin p 71
###xml 36 37 36 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 209 216 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t02">table 2</xref>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 961 962 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 985 990 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1390 1393 1390 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1463 1464 1463 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1464 1465 1464 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1465 1466 1465 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1466 1468 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1527 1534 1527 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t02">table 2</xref>
###xml 1536 1537 1536 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 335 342 <span type="species:ncbi:9606">patient</span>
###xml 427 434 <span type="species:ncbi:9606">patient</span>
###xml 540 547 <span type="species:ncbi:9606">patient</span>
###xml 1292 1299 <span type="species:ncbi:9606">patient</span>
###xml 1543 1550 <span type="species:ncbi:9606">patient</span>
###xml 1569 1574 <span type="species:ncbi:9606">woman</span>
Excluding previous NCI BHDS reports,6 overall in the literature five of 77 (6.5%) individuals with BHD germline mutations had a recorded medical history of kidney tumours and/or renal tumour on renal imaging (table 2). The age at diagnosis of a renal tumour ranged from 20-55 years.5815 Khoo and co-workers reported a 65-year-old BHDS patient with a history of right nephrectomy at age 20 for clear cell RCC, and an additional patient who at age 35 had a nephrectomy for an 8 cm "malignant oncocytoma" infiltrating the capsule.5 The latter patient developed metastatic disease involving the right upper lobe of the lung which upon thoracotomy revealed metastatic RCC with papillary structures. Microscopic re-examination of tumour tissue revealed unclassified RCC, Fuhrman grade 4.5 Leter and co-workers reported an individual with a history of RCC who had unilateral mixed papillary and clear cell RCC at age 39 and a year later died due to metastatic disease.8 In addition, Murakami et al reported a 55-year-old who at the time of nephrectomy had a 9.5 cm single solid mass, an inferior vena cava tumour thrombus and lung metastasis.15 Microscopic examination of renal tumour showed tubular and tubulo-papillary areas with mainly eosinophilic neoplastic cells and focally clear cells. This patient died of metastatic disease 27 months after nephrectomy. Of 50 individuals with a germline BHD mutation who were screened for kidney tumours by other investigators,57-15 only one had a renal tumour detected on baseline imaging (table 2).8 This patient was a 40-year-old woman with histologically confirmed trichodiscoma who was referred by the dermatologist for renal imaging. Renal work-up revealed RCC with elements of oncocytoma.
###end p 71
###begin p 72
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t02">table 2</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 488 489 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 284 292 <span type="species:ncbi:9606">patients</span>
###xml 326 334 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
In our previous study, we found that 33% (57/171) of patients with BHD germline mutations for whom medical history was available reported a history of spontaneous pneumothorax and 87% (95/109) of BHDS who were screened by chest CT scan had one or more lung cysts.6 Excluding the BHDS patients reported by NCI,6 77% (23/30) of patients reported with BHD germline mutations had lung cysts on CT imaging and 40% (33/82) of patients reported a history of spontaneous pneumothorax (table 2).57-15
###end p 72
###begin title 73
DISCUSSION
###end title 73
###begin p 74
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 458 463 458 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0321-f03">fig 3</xref>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 736 739 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 741 746 741 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="jmg-45-06-0321-f02">fig 2</xref>
###xml 1206 1209 1206 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1329 1332 1329 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 952 959 <span type="species:ncbi:9606">patient</span>
###xml 1483 1487 <span type="species:ncbi:9615">dogs</span>
We report the clinical findings in 50 new families with BHDS and 13 novel BHD germline mutations. We identified BHD mutations in 88% of BHDS families which is slightly higher than our previously reported mutation detection rate of 84%.6 In combination with our previous reports,46 to date we have reported 102 families and 36 unique BHD germline mutations including 21 insertion/deletions, eight putative splice site, six nonsense and one missense mutation (fig 3). Including the present study and all cases worldwide, 53 unique germline BHD mutations have been reported affecting all translated exons (4-14), with the exception of exons 8 and 10 (4-15). In this investigation, we report the first germline missense mutation (K508R) in BHD (fig 2). Using sequence alignment, we found that the lysine508 amino acid in folliculin is conserved in vertebrate and invertebrate species suggesting functional significance. The K508R mutation was present in a patient with bilateral multifocal renal oncocytomas, a phenotype commonly seen in BHDS, suggesting that it is a disease-causing mutation. This mutation was not present in DNA from 160 unrelated control individuals. Therefore, although uncommon, germline BHD missense mutations may occur in BHDS. This is not surprising since a missense mutation in exon 7 (H255R) in the canine BHD ortholog is the disease-associated germline mutation in hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in German shepherd dogs.21 The H255R mutation confers an amino acid change in a highly conserved histidine of folliculin.
###end p 74
###begin title 75
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
BHD germline mutation reported by the National Cancer Institute (NCI) group and other investigators. (A) Illustration of the 55 germline BHD mutations identified by the NCI. The 23 unique BHD mutations identified in the present study are shown in red. The star indicates mutations identified in both the present study and the previous NCI study.6 The 22 unique mutations previously reported by NCI are shown in black.6 (B) Lower panel shows the 18 germline BHD mutations reported by other investigators.57-15 Mutations shown in blue were identified by both the NCI group and other investigators. The parenthesis show the original nomenclature used in the original reports.
###end title 75
###begin p 76
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1212 1215 1212 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1377 1379 1377 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1425 1428 1425 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1576 1577 1576 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1577 1578 1577 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1578 1579 1578 1579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1579 1581 1579 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 388 396 <span type="species:ncbi:9606">patients</span>
###xml 1005 1013 <span type="species:ncbi:9606">patients</span>
###xml 1198 1206 <span type="species:ncbi:9606">patients</span>
###xml 1409 1417 <span type="species:ncbi:9606">patients</span>
Including the present study, 70 patients with BHD germline mutation and kidney tumours have been reported in the literature.56815 In the present NCI study, the age at diagnosis of kidney tumours was similar to our previous reports631 and reports by other investigators.57-15 Even though in the present study we did not identify BHDS patients with metastatic kidney cancer, only five BHDS patients with BHD mutations who died of metastatic kidney cancer have been reported to date.581531 These individuals with metastatic kidney cancer had tumours with clear cell, tubulo-papillary and/or papillary histologic features. These histologic features are slightly different from most kidney tumours associated with BHDS. BHDS is associated with a unique histological spectrum of bilateral and multifocal kidney tumours ranging from hybrid oncocytic (67%) to chromophobe RCC (23%) to oncocytic (3%).31 Clear cell RCC (3%) has also been reported in a few BHDS cases.31 Prospective studies with a larger number of patients are needed to determine whether the different renal tumour histopathologic subtypes associated with BHDS have different malignant potentials. It is of interest that even though 95% of patients with BHD germline mutations and kidney tumours have been reported by the NCI, to our knowledge only two cases from the NCI group have developed metastatic kidney disease.31 In contrast, only a few BHDS patients with a BHD germline mutation have been reported by other investigators to have kidney tumours, and most (three of five) of these cases had metastatic disease.57-15 These differences may be a reflection of the different ascertainment and screening methodologies for kidney tumour used by different research groups.
###end p 76
###begin p 77
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
###xml 1111 1119 <span type="species:ncbi:9606">patients</span>
The present investigation confirms the high prevalence of kidney tumours in our BHDS families. Previously, we observed a sevenfold increased risk of renal tumours in patients with BHDS.32 In the present study, using a combined ascertainment in dermatologic and urologic oncology clinics at NCI, the overall prevalence of kidney tumours among individuals with germline BHD mutations was 34%. This frequency is higher than our previous report (23%)6 and much higher than the frequency of kidney tumours in BHDS cases combined from other investigators (6.5%). We also observed that BHDS patients with a family history of kidney tumours had a statistically significant risk of developing kidney tumours compared with BHDS patients without a family history of kidney tumours (p = 0.0015). The risk remained significant when we excluded cases ascertained on the basis of kidney tumour. Kidney tumour is also a major phenotypic feature with high penetrance in the naturally occurring BHDS animal models.1718 However, other genetic and environmental factors may also be involved in the development of kidney tumours in patients of BHDS and animal models.
###end p 77
###begin p 78
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 830 833 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 961 964 961 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 969 972 969 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bhd</italic>
###xml 1040 1043 1040 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1130 1133 1130 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 398 406 <span type="species:ncbi:9606">patients</span>
###xml 580 588 <span type="species:ncbi:9606">patients</span>
###xml 700 707 <span type="species:ncbi:9606">patient</span>
###xml 912 920 <span type="species:ncbi:9606">patients</span>
Renal tumours associated with BHDS may have a higher impact on morbidity than on mortality. The presence of oncocytosis in the renal parenchyma at surgery or at postmortem examination of patients with BHDS is histologic evidence of the potential of kidney tumour development in BHDS patients. The diagnosis in a family member and surveillance of families with BHDS should lead to identification of patients at high risk of BHDS kidney tumours and to early detection and treatment. The use of nephron sparing surgery rather than radical nephrectomy decreases the morbidity of BHDS patients with renal tumours by preserving renal functional tissue. The diagnosis of BHDS is of critical importance in a patient presenting with kidney tumours since the management of these tumours is different from sporadic kidney tumours.31 Somatic BHD mutations or LOH at the BHD locus have been detected in 70% of RCCs from BHDS patients.24 The high frequency of second hits in BHD and bhd supports that it is a tumour suppressor gene. Inactivation of both BHD alleles occurs in several histologic subtypes of RCC, suggesting that inactivation of BHD occurs at an early stage of renal tumorigenesis.24
###end p 78
###begin p 79
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 735 738 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 483 491 <span type="species:ncbi:9606">patients</span>
###xml 624 632 <span type="species:ncbi:9606">patients</span>
###xml 1141 1149 <span type="species:ncbi:9606">patients</span>
In the present study, we found that 84% of patients with BHD germline mutations have pulmonary cysts on chest CT. This is very similar to our previous study (89%)6 but slightly higher than other reports combined (77%)57-15 In the present study we found that 38% (34/89) of individuals with a BHD germline mutation had a history of spontaneous pneumothorax. This is very similar to all other studies combined and our previous study (33%).6 In the present study, we also observed that patients with BHDS and a family history of pneumothorax had a statistically significant increased risk of pneumothorax when compared to BHDS patients without a family history of spontaneous pneumothorax. This supports previous reports of families with BHD mutations and a prominent and almost exclusive spontaneous pneumothorax inherited in an autosomal dominant fashion.1011 Most cases with lung phenotype without other cutaneous or renal manifestations probably are undetected cases of BHDS since they are from cross sectional studies and cases may develop other manifestations with time. Therefore, prospective follow-up clinical studies of this group of patients are needed to understand better how they fit within the spectrum of clinical manifestations of BHDS.
###end p 79
###begin p 80
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 1168 1169 1168 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
###xml 807 815 <span type="species:ncbi:9606">patients</span>
Previously, we reported a 50-fold increased risk for the development of spontaneous pneumothorax in patients with BHDS compared with family members unaffected by BHDS.32 The role of lung cysts in the mechanism leading to a spontaneous pneumothorax in BHDS had not been established. Lung cysts appear to be a precursor lesion leading to a spontaneous pneumothorax. Recently, we reported that total lung cyst volume, largest cyst diameter and volume, as well as every parameter associated with lung cysts which we evaluated, were significantly associated with pneumothorax in patients with BHDS.33 Haploinsufficiency may be responsible for the development of lung cysts, skin lesion and other hamartomas associated with BHDS. We have not observed increased mortality or progressive lung deterioration in BHDS patients with lung cysts or pneumothorax. The lung phenotype (history of spontaneous pneumothorax and lung cysts) associated with BHDS is a prominent feature that helps to distinguish BHDS from other inherited kidney cancer syndromes (von Hippel-Lindau syndrome, hereditary leiomyomatosis and renal cell cancer, and hereditary papillary renal cell carcinoma).34-37
###end p 80
###begin p 81
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 473 476 473 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 837 840 837 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1283 1284 1283 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 1329 1331 1329 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 1446 1447 1446 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1447 1449 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 1449 1450 1449 1450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1450 1452 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 942 949 <span type="species:ncbi:9606">patient</span>
###xml 1427 1435 <span type="species:ncbi:9606">patients</span>
We also report in this study for the first time families with germline mutations in BHD and angiofibroma, perifollicular fibroma or both angiofibroma and perifollicular fibromas as their only BHDS cutaneous phenotype. Our findings support that BHDS is associated with a spectrum of cutaneous hamartomas ranging from AF to PFF to FF. BHDS associated hamartomas should be distinguish it from other genodermatoses with an increased risk for internal malignancy.38 Recently, a BHD mutation was reported in one of three families with only trichodiscomas.8 However, two of the three families had an atypical presentation and most likely do not have BHDS. In addition, we previously reported additional individuals with BHD germline mutations and trichodiscomas.6 It is of interest that we identified two individuals with germline mutations in BHD who also had a history of malignant melanoma. Only one previous confirmed case of melanoma in a BHDS patient has been reported.5 We also identified a BHDS family in whom one sibling developed a DFSP and another sibling had a cutaneous leiomyosarcoma. These tumours are rare and not previously reported in BHDS. We also identified two additional individuals with parotid gland tumours for a total of six cases in our group of 102 BHDS families6 and a total of eight cases reported to date.39 Most of the other internal neoplasms identified in this study have been previously reported in patients with BHDS.540-45 However, determining whether they are part of the clinical spectrum of BHDS remains to be investigated in further studies.
###end p 81
###begin p 82
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
In this study, we investigated potential genotype-phenotype relationships in our patients with BHDS. In general, we found no associations between specific BHD mutations or mutation types (intron vs exon; frameshift, nonsense, missense) and clinical phenotype (FF, TD/AF, PFF, renal tumours, spontaneous pneumothorax, or lung cysts). Previously, we reported that individuals with an BHD IVS9+2 mutation had a higher frequency of kidney tumours compared to all mutation carriers.6 In this study, only one family had this same mutation, thus this observation could not be confirmed. It is possible that aberrant mutant BHD proteins produced by splice site mutations have functional consequences and lead to renal tumorigenesis.
###end p 82
###begin p 83
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
Each of our independent studies and combined analyses showed that c.1733insC and c.1733delC mutation carriers had similar frequencies of FFs, lung cysts and pneumothoraces. In a previous study, we found that the frequency of renal tumours in c.1733delC carriers was lower than the frequency of renal tumours in c.1733insC carriers.6 However, analysis of combined data from both studies showed no significant differences in frequencies of renal tumours among both groups. Future studies with combined data from large cohorts of BHDS families should have enough statistical power to confirm our studies and evaluate other potential genotype-phenotype correlations.
###end p 83
###begin p 84
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 227 228 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 526 533 526 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="jmg-45-06-0321-t01">table 1</xref>
###xml 642 645 642 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 795 798 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
The majority of BHD germline mutations identified in this investigation, both of our studies combined and all studies combined, are predicted to produce a C-terminally truncated folliculin (FLCN) resulting in loss of function.4-15 In this study, we report a mutation in a family in which a BHD mutation was not previously detected.6 Re-sequencing DNA from family 240, who linked to chromosome 17p11.2, revealed that affected haplotype carriers had a putative splice site mutation in the BHD gene within intron 4 (IVS4-2 A>G) (table 1). However, we did not identify sequence variations in the coding region and 3' and 5' regulatory regions of BHD in seven additional families despite two attempts using direct DNA sequencing. Future studies will include screening families for large deletions in BHD.
###end p 84
###begin p 85
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 464 489 464 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 464 489 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 712 717 <span type="species:ncbi:4932">yeast</span>
###xml 824 829 <span type="species:ncbi:4932">yeast</span>
Recently, Baba and co-workers26 reported that FLCN interacts with FNIP1 through its C terminus. Therefore, germline mutations predicted to produce a C-terminally truncated FLCN would be unable to bind FNIP1. These investigators also showed that FLCN phosphorylation facilitated by FNIP1 is reduced by inhibitors of mTOR and AMPK activity implicating FLCN/FNIP1 in the AMPK and mTOR signalling pathways.26 Recently, Henske and co-workers deleted the BHD homolog in Schizosaccharomyces pombe.46 They showed that expression profiling revealed that six permease and transporter genes, known to be down-regulated in Deltatsc1 and Deltatsc2, were up-regulated in Deltabhd. They also showed that loss of Bhd sensitised yeast to rapamycin induced increases in permease expression levels, and rapamycin induced lethality in Deltabhd yeast expressing the hypomorphic Rhb1 allele.46 These results suggest that Bhd activates Tor2.
###end p 85
###begin p 86
###xml 440 443 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDH</italic>
###xml 571 574 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 492 500 <span type="species:ncbi:9606">patients</span>
Advances in the diagnosis of BHDS using molecular genetic techniques has allowed us to expand the BHDS phenotypic spectrum of associated hamartomas and tumours, and demonstrate clinical heterogeneity both within and among BHDS families. Although we report a large group of families, our dataset is too small to examine genotype-phenotype correlations rigorously. However, this should be possible in the future by combining our clinical and BDH mutation data on clinically well described BHDS patients and families with that from other centres. Future characterisation of BHD mutations and genotype-phenotype correlations in BHDS may provide valuable insights into the molecular pathogenesis of BHDS. Future clinical studies and laboratory investigations using in vitro systems and animal models may help us to elucidate the sequence of pathogenetic events that lead to the clinical findings and the organ preference of involvement that we observe in BHDS.
###end p 86
###begin p 87
We thank the BHD families for their participation in our study, and the members of the American Academy of Dermatology for their help in the recruitment of families. We also thank Martha Ninos, Sarah Fowler, and Lindsay Middelton for their many contributions to this project.
###end p 87
###begin title 88
REFERENCES
###end title 88
###begin article-title 89
Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons.
###end article-title 89
###begin article-title 90
Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia.
###end article-title 90
###begin article-title 91
Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2.
###end article-title 91
###begin article-title 92
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome.
###end article-title 92
###begin article-title 93
Clinical and genetic studies of Birt-Hogg-Dube syndrome.
###end article-title 93
###begin article-title 94
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome.
###end article-title 94
###begin article-title 95
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dube patients.
###end article-title 95
###begin article-title 96
Birt-Hogg-Dube syndrome: clinical and genetic studies of 20 families.
###end article-title 96
###begin article-title 97
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax.
###end article-title 97
###begin article-title 98
Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults.
###end article-title 98
###begin article-title 99
A 4-bp deletion in the Birt-Hogg-Dube gene (FLCN) causes dominantly inherited spontaneous pneumothorax.
###end article-title 99
###begin article-title 100
Detection of 1733insC mutations in an Asian family with Birt-Hogg-Dube syndrome.
###end article-title 100
###begin article-title 101
###xml 104 111 <span type="species:ncbi:9606">patient</span>
Birt-Hogg-Dube syndrome: germline mutation in the (C)8 mononucleotide tract of the BHD gene in a German patient.
###end article-title 101
###begin article-title 102
###xml 79 86 <span type="species:ncbi:9606">patient</span>
A novel familial germline mutation in the initiator codon of the BHD gene in a patient with Birt-Hogg-Dube syndrome.
###end article-title 102
###begin article-title 103
Identification and characterization of Birt-Hogg-Dube associated renal carcinoma.
###end article-title 103
###begin article-title 104
Analysis of the Birt-Hogg-Dube (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
###end article-title 104
###begin article-title 105
###xml 99 102 <span type="species:ncbi:9615">dog</span>
Hereditary multifocal renal cystadenocarcinomas and nodular dermatofibrosis in the German shepherd dog: macroscopic and histopathologic changes.
###end article-title 105
###begin article-title 106
###xml 77 81 <span type="species:ncbi:9615">dogs</span>
Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs.
###end article-title 106
###begin article-title 107
###xml 55 58 <span type="species:ncbi:10116">rat</span>
A novel renal carcinoma predisposing gene of the Nihon rat maps on chromosome 10.
###end article-title 107
###begin article-title 108
###xml 16 19 <span type="species:ncbi:10116">rat</span>
A novel "Nihon" rat model of a Mendelian dominantly inherited renal cell carcinoma.
###end article-title 108
###begin article-title 109
###xml 151 154 <span type="species:ncbi:9615">dog</span>
A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German shepherd dog.
###end article-title 109
###begin article-title 110
###xml 79 82 <span type="species:ncbi:10116">rat</span>
A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer.
###end article-title 110
###begin article-title 111
###xml 59 64 <span type="species:ncbi:9606">human</span>
Expression of Birt-Hogg-Dube mRNA in normal and neoplastic human tissues.
###end article-title 111
###begin article-title 112
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors.
###end article-title 112
###begin article-title 113
###xml 4 14 <span type="species:ncbi:7227">Drosophila</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance.
###end article-title 113
###begin article-title 114
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
###end article-title 114
###begin article-title 115
A network algorithm for performing Fisher's exact test in r x c contingency tables.
###end article-title 115
###begin article-title 116
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
###end article-title 116
###begin article-title 117
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
###end article-title 117
###begin article-title 118
Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome.
###end article-title 118
###begin article-title 119
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome.
###end article-title 119
###begin article-title 120
Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dube syndrome.
###end article-title 120
###begin article-title 121
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.
###end article-title 121
###begin article-title 122
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.
###end article-title 122
###begin article-title 123
Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer.
###end article-title 123
###begin article-title 124
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.
###end article-title 124
###begin article-title 125
Exclusion of PTEN, CTNNB1, and PTCH as candidate genes for Birt-Hogg-Dube syndrome.
###end article-title 125
###begin article-title 126
Parotid oncocytoma in the Birt-Hogg-Dube syndrome.
###end article-title 126
###begin article-title 127
Generalized dermal perifollicular fibroma with polyps of the colon.
###end article-title 127
###begin article-title 128
Fibrofolliculomas, trichodiscomas and acrochordons (Birt-Hogg-Dube) associated with intestinal polyposis.
###end article-title 128
###begin article-title 129
Multiple trichodiscomas associated with colonic polyposis.
###end article-title 129
###begin article-title 130
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Birt-Hogg-Dube syndrome: two patients with neural tissue tumors.
###end article-title 130
###begin article-title 131
Mutations of the Birt-Hogg-Dube (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability.
###end article-title 131
###begin article-title 132
###xml 62 69 <span type="species:ncbi:9606">patient</span>
Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome.
###end article-title 132
###begin article-title 133
###xml 108 133 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe.
###end article-title 133
###begin p 134
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests:</bold>
Competing interests: None declared.
###end p 134
###begin p 135
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
###xml 483 488 <span type="species:ncbi:9606">Human</span>
Funding: This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and the Division of Cancer Epidemiology and Genetics. This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract no. NO1-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organisations imply endorsement by the US government.
###end p 135
###begin p 136
###xml 0 16 0 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Patient consent:</bold>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Patient consent: Informed consent was obtained from the patients and family members for publication of this report.
###end p 136

